Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lopinavir/ritonavir in HIV-infected subjects
NCT00043953Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Aug 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of saquinavir in human immunodeficiency virus infection (HIV), sponsored by Abbott Laboratories. Started Aug 2002; status: completed.
02
Drugs
saquinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00043953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043953.